AKR1C3-IN-7
AKR1C3-IN-7 (Compound 13) is a potent, selective AKR1C3 inhibitor with an IC50 of 0.19 μM. AKR1C3-IN-7 shows antitumor activity[1].
Product Specifications
UNSPSC
12352005
Target
17β-HSD; Aldose Reductase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/akr1c3-in-7.html
Solubility
10 mM in DMSO
Smiles
COC1=CC=C(C=C1)CC2=C(C(O)=NO2)C(NC3=CC(C4=CC=CC=C4)=CC=C3)=O
Molecular Formula
C24H20N2O4
Molecular Weight
400.43
References & Citations
[1]Pippione AC, et al. New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold. Eur J Med Chem. 2022 Jul 5;237:114366.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-146574/AKR1C3-IN-7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-146574/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
